PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 31 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,022,000 | +16.6% | 3,365,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $2,591,000 | -11.0% | 3,365,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,911,000 | -8.7% | 3,365,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $3,190,000 | -64.7% | 3,365,000 | -64.3% | 0.00% | -50.0% |
| Q1 2015 | $9,029,000 | +27.3% | 9,436,000 | +27.2% | 0.00% | 0.0% |
| Q4 2014 | $7,091,000 | +35.8% | 7,416,000 | +38.4% | 0.00% | +100.0% |
| Q3 2014 | $5,220,000 | +11.5% | 5,360,000 | +31.1% | 0.00% | 0.0% |
| Q2 2014 | $4,681,000 | – | 4,089,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|